VSee Health Names Dr. Milton Chen as Chairman to Drive AI Infrastructure Growth
Appointment strengthens execution as the company accelerates AI infrastructure growth. SAN JOSE, CA / ACCESS Newswire / November 20, 2025...
Healthcare
VSee Health Names Dr. Milton Chen as Chairman to Drive AI Infrastructure Growth
Appointment strengthens execution as the company accelerates AI infrastructure growth. SAN JOSE, CA / ACCESS Newswire / November 20, 2025...
Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach
~ FDA Response Streamlines Path to Commercial Production of PF614~ SAN DIEGO, CA / ACCESS Newswire / November 20, 2025...
Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach
~ FDA Response Streamlines Path to Commercial Production of PF614~ SAN DIEGO, CA / ACCESS Newswire / November 20, 2025...
TriageLogic’s MedMessage Automate Saves 400+ Staff Minutes per Week
Automated intake captures accurate patient messages, streamlines clinical tasks, and helps practices regain valuable staff time. JACKSONVILLE, FL / ACCESS...
TriageLogic’s MedMessage Automate Saves 400+ Staff Minutes per Week
Automated intake captures accurate patient messages, streamlines clinical tasks, and helps practices regain valuable staff time. JACKSONVILLE, FL / ACCESS...
Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2025 financial guidance provided on 3Q25...
Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2025 financial guidance provided on 3Q25...
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine...
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine...
ESSE Care Welcomes Dr. Amanda Chu, Expanding Complex Minimally Invasive Surgery Offerings and Endometriosis Specialty Care
With elite training in endometriosis excision and a commitment to whole-body, multidisciplinary care, Dr. Chu expands ESSE's mission of integrative,...
ESSE Care Welcomes Dr. Amanda Chu, Expanding Complex Minimally Invasive Surgery Offerings and Endometriosis Specialty Care
With elite training in endometriosis excision and a commitment to whole-body, multidisciplinary care, Dr. Chu expands ESSE's mission of integrative,...
Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
VANCOUVER, British Columbia and LAS VEGAS, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:...
Johns Hopkins Health Plans Welcomes Inova Health To Medicare Advantage Network
Relationship Enhances Care Access as Advantage MD Expands Virginia Service AreaHANOVER, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Effective Jan....
Shattuck Labs to Participate in Upcoming December Investor Conferences
AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK),...
Nanox Announces Third Quarter of 2025 Financial Results and Provides Business Update
Management to host conference call and webcast Thursday, November 20, 2025, at 8:30 AM ET Company advances commercialization and is on...
4DMT to Participate in 8th Annual Evercore Healthcare Conference
EMERYVILLE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage...
Opus Genetics to Participate in Upcoming Investment Conferences
RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”),...
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
BELTSVILLE, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
—Nebokitug PSC Phase 3 Design Near Completion Following Positive FDA Feedback— —Regulatory Alignment Advances, with EMA Guidance Supporting a Single...